BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25936231)

  • 1. Current use of oral contraceptives and the risk of first-ever ischemic stroke: A meta-analysis of observational studies.
    Xu Z; Li Y; Tang S; Huang X; Chen T
    Thromb Res; 2015 Jul; 136(1):52-60. PubMed ID: 25936231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of ischemic stroke among users of the oral contraceptive pill: The Melbourne Risk Factor Study (MERFS) Group.
    Siritho S; Thrift AG; McNeil JJ; You RX; Davis SM; Donnan GA;
    Stroke; 2003 Jul; 34(7):1575-80. PubMed ID: 12805499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke.
    Roach RE; Helmerhorst FM; Lijfering WM; Stijnen T; Algra A; Dekkers OM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011054. PubMed ID: 26310586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of low-dose oral contraceptives and stroke in young women.
    Schwartz SM; Siscovick DS; Longstreth WT; Psaty BM; Beverly RK; Raghunathan TE; Lin D; Koepsell TD
    Ann Intern Med; 1997 Oct; 127(8 Pt 1):596-603. PubMed ID: 9341057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
    Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
    Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence.
    Chan WS; Ray J; Wai EK; Ginsburg S; Hannah ME; Corey PN; Ginsberg JS
    Arch Intern Med; 2004 Apr; 164(7):741-7. PubMed ID: 15078643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke in users of low-dose oral contraceptives.
    Petitti DB; Sidney S; Bernstein A; Wolf S; Quesenberry C; Ziel HK
    N Engl J Med; 1996 Jul; 335(1):8-15. PubMed ID: 8637557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contraceptives and cerebral thrombosis: a five-year national case-control study.
    Lidegaard Ø; Kreiner S
    Contraception; 2002 Mar; 65(3):197-205. PubMed ID: 11929641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between oral contraceptives and risk of hemorrhagic stroke: a meta-analysis of observational studies.
    Xu Z; Yue Y; Bai J; Shen C; Yang J; Huang X; Zhao Y; Li Y
    Arch Gynecol Obstet; 2018 May; 297(5):1181-1191. PubMed ID: 29460112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke and use of low-dose oral contraceptives in young women: a pooled analysis of two US studies.
    Schwartz SM; Petitti DB; Siscovick DS; Longstreth WT; Sidney S; Raghunathan TE; Quesenberry CP; Kelaghan J
    Stroke; 1998 Nov; 29(11):2277-84. PubMed ID: 9804634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis.
    Peragallo Urrutia R; Coeytaux RR; McBroom AJ; Gierisch JM; Havrilesky LJ; Moorman PG; Lowery WJ; Dinan M; Hasselblad V; Sanders GD; Myers ER
    Obstet Gynecol; 2013 Aug; 122(2 Pt 1):380-389. PubMed ID: 23969809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemic stroke risk with oral contraceptives: A meta-analysis.
    Gillum LA; Mamidipudi SK; Johnston SC
    JAMA; 2000 Jul; 284(1):72-8. PubMed ID: 10872016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited thrombophilia and stratification of ischaemic stroke risk among users of oral contraceptives.
    Pezzini A; Grassi M; Iacoviello L; Del Zotto E; Archetti S; Giossi A; Padovani A
    J Neurol Neurosurg Psychiatry; 2007 Mar; 78(3):271-6. PubMed ID: 17098841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal contraceptives and arterial disease: an epidemiological update.
    Plu-Bureau G; Hugon-Rodin J; Maitrot-Mantelet L; Canonico M
    Best Pract Res Clin Endocrinol Metab; 2013 Feb; 27(1):35-45. PubMed ID: 23384744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The formulation of oral contraceptives: does the amount of estrogen make any clinical difference?
    Speroff L
    Johns Hopkins Med J; 1982 May; 150(5):170-6. PubMed ID: 7043035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives and stroke.
    Bousser MG; Kittner SJ
    Cephalalgia; 2000 Apr; 20(3):183-9. PubMed ID: 10997772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adverse effects of hormonal therapy.
    Bush TL
    Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.
    Cole JA; Norman H; Doherty M; Walker AM
    Obstet Gynecol; 2007 Feb; 109(2 Pt 1):339-46. PubMed ID: 17267834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of estrogen and progestin potency of oral contraceptives with ovarian carcinoma risk.
    Lurie G; Thompson P; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Obstet Gynecol; 2007 Mar; 109(3):597-607. PubMed ID: 17329510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review.
    Wu CQ; Grandi SM; Filion KB; Abenhaim HA; Joseph L; Eisenberg MJ
    BJOG; 2013 Jun; 120(7):801-10. PubMed ID: 23530659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.